Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
150
NCT05562843
Autologous Cellular Therapy With PRP-PC in Chronic Lung Diseases: An Observational Study LI-004
Phase: N/A
Role: Lead Sponsor
Start: Jun 10, 2021
Completion: Aug 1, 2022